This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Novartis Ag. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Xiang Gao: Innovator in Hydroquinazoline Derivatives
Introduction
Xiang Gao is a notable inventor based in Cambridge, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for medical treatments. His innovative work has led to the filing of a patent that addresses important health issues.
Latest Patents
Xiang Gao holds a patent for "Hydroquinazoline derivatives for the treatment of a disease or disorder." This patent relates to a compound of Formula (I) or a pharmaceutically acceptable salt thereof, wherein A, Rto R, and Rto R, are as described in the patent documentation. This invention has the potential to impact the treatment of various diseases and disorders.
Career Highlights
Xiang Gao is currently associated with Novartis AG, a leading global healthcare company. His role at Novartis allows him to work on cutting-edge research and development projects that aim to improve patient outcomes through innovative therapies.
Collaborations
Xiang collaborates with esteemed colleagues such as Daniela Angst and Philippe Bolduc. These partnerships enhance the research environment and foster the development of new therapeutic solutions.
Conclusion
Xiang Gao's contributions to the field of pharmaceuticals through his patent on hydroquinazoline derivatives exemplify the importance of innovation in medical science. His work at Novartis AG and collaborations with other professionals further highlight his commitment to advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
